A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating γ-retroviral vectors using targeted integration (original) (raw)
Cavazzana-Calvo M, Thrasher A, Mavilio F . The future of gene therapy. Nature 2004; 427: 779–781. ArticleCASPubMed Google Scholar
Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay JP et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. New Engl J Med 2002; 346: 1185–1193. ArticleCASPubMed Google Scholar
Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002; 296: 2410–2413. ArticleCASPubMed Google Scholar
Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 2009; 360: 447–458. CASPubMed Google Scholar
Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 2006; 12: 401–409. ArticleCASPubMed Google Scholar
Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. New Engl J Med 2003; 348: 255–256. ArticlePubMed Google Scholar
Zychlinski D, Schambach A, Modlich U, Maetzig T, Meyer J, Grassman E et al. Physiological promoters reduce the genotoxic risk of integrating gene vectors. Mol Ther 2008; 16: 718–725. ArticleCASPubMed Google Scholar
Montini E, Cesana D, Schmidt M, Sanvito F, Ponzoni M, Bartholomae C et al. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 2006; 24: 687–696. ArticleCASPubMed Google Scholar
Montini E, Cesana D, Schmidt M, Sanvito F, Bartholomae CC, Ranzani M et al. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest 2009; 119: 964–975. ArticleCASPubMedPubMed Central Google Scholar
Modlich U, Bohne J, Schmidt M, von Kalle C, Knoss S, Schambach A et al. Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood 2006; 108: 2545–2553. ArticleCASPubMedPubMed Central Google Scholar
Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463–8471. CASPubMedPubMed Central Google Scholar
Negre D, Cosset FL . Vectors derived from simian immunodeficiency virus (SIV). Biochimie 2002; 84: 1161–1171. ArticleCASPubMed Google Scholar
Yu SF, von Ruden T, Kantoff PW, Garber C, Seiberg M, Ruther U et al. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci USA 1986; 83: 3194–3198. ArticleCASPubMedPubMed Central Google Scholar
Schambach A, Wodrich H, Hildinger M, Bohne J, Krausslich HG, Baum C . Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol Ther 2000; 2: 435–445. ArticleCASPubMed Google Scholar
Schambach A, Bohne J, Chandra S, Will E, Margison GP, Williams DA et al. Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells. Mol Ther 2006; 13: 391–400. ArticleCASPubMed Google Scholar
Schambach A, Swaney WP, Loo JC . Design and production of retro- and lentiviral vectors for gene expression in hematopoietic cells. Methods Mol Biol 2009; 506: 191–205. ArticleCASPubMed Google Scholar
Bode J, Schlake T, Iber M, Schubeler D, Seibler J, Snezhkov E et al. The transgeneticist's toolbox: novel methods for the targeted modification of eukaryotic genomes. Biol Chem 2000; 381: 801–813. ArticleCASPubMed Google Scholar
Wirth D, Gama-Norton L, Riemer P, Sandhu U, Schucht R, Hauser H . Road to precision: recombinase-based targeting technologies for genome engineering. Curr Opin Biotechnol 2007; 18: 411–419. ArticleCASPubMed Google Scholar
Schucht R, Coroadinha AS, Zanta-Boussif MA, Verhoeyen E, Carrondo MJ, Hauser H et al. A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors. Mol Ther 2006; 14: 285–292. ArticleCASPubMed Google Scholar
Coroadinha AS, Schucht R, Gama-Norton L, Wirth D, Hauser H, Carrondo MJ . The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange. J Biotechnol 2006; 124: 457–468. ArticleCASPubMed Google Scholar
Verhoeyen E, Hauser H, Wirth D . Evaluation of retroviral vector design in defined chromosomal loci by Flp-mediated cassette replacement. Hum Gene Ther 2001; 12: 933–944. ArticleCASPubMed Google Scholar
Miller AD, Garcia JV, von Suhr N, Lynch CM, Wilson C, Eiden MV . Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol 1991; 65: 2220–2224. CASPubMedPubMed Central Google Scholar
Gaspar HB, Parsley KL, Howe S, King D, Gilmour KC, Sinclair J et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 2004; 364: 2181–2187. ArticleCASPubMed Google Scholar
Schlake T, Bode J . Use of mutated FLP recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci. Biochemistry 1994; 33: 12746–12751. ArticleCASPubMed Google Scholar
Riviere I, Brose K, Mulligan RC . Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA 1995; 92: 6733–6737. ArticleCASPubMedPubMed Central Google Scholar
Schambach A, Mueller D, Galla M, Verstegen MM, Wagemaker G, Loew R et al. Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Therapy 2006; 13: 1524–1533. ArticleCASPubMed Google Scholar
Armentano D, Yu SF, Kantoff PW, von Ruden T, Anderson WF, Gilboa E . Effect of internal viral sequences on the utility of retroviral vectors. J Virol 1987; 61: 1647–1650. CASPubMedPubMed Central Google Scholar
Adam MA, Miller AD . Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions. J Virol 1988; 62: 3802–3806. CASPubMedPubMed Central Google Scholar
Schambach A, Galla M, Maetzig T, Loew R, Baum C . Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors. Mol Ther 2007; 15: 1167–1173. ArticleCASPubMed Google Scholar
Moreno-Carranza B, Gentsch M, Stein S, Schambach A, Santilli G, Rudolf E et al. Transgene optimization significantly improves SIN vector titers, gp91(phox) expression and reconstitution of superoxide production in X-CGD cells. Gene Therapy 2009; 16: 111–118. ArticleCASPubMed Google Scholar
Thornhill SI, Schambach A, Howe SJ, Ulaganathan M, Grassman E, Williams D et al. Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency. Mol Ther 2008; 16: 590–598. ArticleCASPubMed Google Scholar
Cosset FL, Takeuchi Y, Battini JL, Weiss RA, Collins MK . High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430–7436. CASPubMedPubMed Central Google Scholar
Lindemann D, Patriquin E, Feng S, Mulligan RC . Versatile retrovirus vector systems for regulated gene expression in vitro and in vivo. Mol Med 1997; 3: 466–476. ArticleCASPubMedPubMed Central Google Scholar
Bueler H, Mulligan RC . Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7–1. Mol Med 1996; 2: 545–555. ArticleCASPubMed Google Scholar
Freas-Lutz DL, Correll PH, Dougherty SF, Xu L, Pluznik DH, Karlsson S . Expression of human glucocerebrosidase in murine macrophages: identification of efficient retroviral vectors. Exp Hematol 1994; 22: 857–865. CASPubMed Google Scholar
Gossen M, Bujard H . Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547–5551. ArticleCASPubMedPubMed Central Google Scholar
Soneoka Y, Cannon PM, Ramsdale EE, Griffiths JC, Romano G, Kingsman SM et al. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 1995; 23: 628–633. ArticleCASPubMedPubMed Central Google Scholar
Pietschmann T, Heinkelein M, Heldmann M, Zentgraf H, Rethwilm A, Lindemann D . Foamy virus capsids require the cognate envelope protein for particle export. J Virol 1999; 73: 2613–2621. CASPubMedPubMed Central Google Scholar
Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–159. ArticleCASPubMed Google Scholar
Loew R, Rausch T . Sensitive, nonradioactive northern blots using alkaline transfer of total RNA and PCR-amplified biotinylated probes. Biotechniques 1994; 17: 1026–1028, 1030. Google Scholar
Gama-Norton L, Herrmann S, Schucht R, Coroadinha A, Loew R, Alves P et al. Retroviral vector performance upon integration in to defined chromosomal loci of modular packaging cell lines. Hum Gene Ther (submitted).